728 related articles for article (PubMed ID: 32180895)
1. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
2. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
3. Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy.
Ford K; Huggins E; Sheean P
J Hum Nutr Diet; 2022 Dec; 35(6):1105-1114. PubMed ID: 35509260
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in transgender individuals correlates with android fat mass.
Bretherton I; Spanos C; Leemaqz SY; Premaratne G; Grossmann M; Zajac JD; Cheung AS
Ther Adv Endocrinol Metab; 2021; 12():2042018820985681. PubMed ID: 33552464
[TBL] [Abstract][Full Text] [Related]
5. Providing Care for Transgender Persons With Kidney Disease: A Narrative Review.
Collister D; Saad N; Christie E; Ahmed S
Can J Kidney Health Dis; 2021; 8():2054358120985379. PubMed ID: 33552529
[TBL] [Abstract][Full Text] [Related]
6. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
7. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function: A Systematic Review and Meta-Analysis.
Krupka E; Curtis S; Ferguson T; Whitlock R; Askin N; Millar AC; Dahl M; Fung R; Ahmed SB; Tangri N; Walsh M; Collister D
Clin J Am Soc Nephrol; 2022 Sep; 17(9):1305-1315. PubMed ID: 35973728
[TBL] [Abstract][Full Text] [Related]
9. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 35831234
[TBL] [Abstract][Full Text] [Related]
10. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
[TBL] [Abstract][Full Text] [Related]
11. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
12. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 37051961
[TBL] [Abstract][Full Text] [Related]
13. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
15. Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.
Haupt C; Henke M; Kutschmar A; Hauser B; Baldinger S; Saenz SR; Schreiber G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013138. PubMed ID: 33251587
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
17. Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth.
Nokoff NJ; Scarbro SL; Moreau KL; Zeitler P; Nadeau KJ; Juarez-Colunga E; Kelsey MM
J Clin Endocrinol Metab; 2020 Mar; 105(3):e704-14. PubMed ID: 31544944
[TBL] [Abstract][Full Text] [Related]
18. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
[TBL] [Abstract][Full Text] [Related]
19. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Gender-Affirming Hormone Therapy on Physical Performance.
Cheung AS; Zwickl S; Miller K; Nolan BJ; Wong AFQ; Jones P; Eynon N
J Clin Endocrinol Metab; 2024 Jan; 109(2):e455-e465. PubMed ID: 37437247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
